Richwood Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ECSS
Richwood Investment Advisors's GILD Position: Q2 2026 in Review
Richwood Investment Advisors reduced its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, selling an estimated $37.6K and leaving 5,873 shares worth $742K. The position accounts for 0.52% of the portfolio, ranked #44.
Richwood Investment Advisors first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $944K in Q4 2025. 965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Richwood Investment Advisors held 5,873 shares of Gilead Sciences worth $742K as of Q2 2026.
- Richwood Investment Advisors sold 285 Gilead Sciences shares in Q2 2026, an estimated $37.6K.
- Gilead Sciences made up 0.52% of Richwood Investment Advisors's portfolio in Q2 2026, its #44 holding.
- Richwood Investment Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
- Richwood Investment Advisors's Gilead Sciences position peaked at $944K in Q4 2025.
- 965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Richwood Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.